AVOLYNT
Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company's mission is to improve the lives of patients suffering from dysfunctions related to human metabolism. Avolynt's team has significant discovery and development experience across the metabolic syndrome, including diabetes, obesity, and nonalcoholic steatohepatitis (NASH). The Company's lead programs are in phase 2 and phase 3.
AVOLYNT
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.avolynt.com
Status:
Active
Contact:
+1 919.659.5677
Email Addresses:
[email protected]
Total Funding:
75 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SSL By Default Euro Apple Mobile Web Clips Icon HSTS Content Delivery Network Google Apps For Business Google Google Cloud
Similar Organizations
Pain Treatment Specialists
Pain Treatment Specialists providing non-surgical treatments for patients suffering from chronic spinal conditions, back and neck pain.
ProCore
ProCore is a biotechnology company developing solutions to improve the quality of life of patients suffering from joint and bone diseases.
Triangle Research Labs
TRL is a fast-growing hepatocyte provider with products supporting in vitro evaluation of metabolism, drug-drug interactions.
Investors List
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Avolynt
Official Site Inspections
http://www.avolynt.com Semrush global rank: 10.49 M Semrush visits lastest month: 294
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Avolynt"
Avolynt - Crunchbase Company Profile & Funding
Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company's mission is to improve the lives of patients suffering from …See details»
About Us - avolynt
Skip to Main Content. Home. MoreSee details»
Avolynt, Inc. - LinkedIn
Avolynt, Inc. | 176 followers on LinkedIn. Avolynt is a clinical stage pharmaceutical company developing novel therapeutics for the treatment of rare and metabolic disease.See details»
Avolynt - Overview, News & Similar companies | ZoomInfo.com
Who is Avolynt. Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company's mission is to improve the lives of patients suffering from …See details»
Avolynt Inc. - VentureRadar
" Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company's mission is to improve the lives of patients suffering from …See details»
Avolynt - Research Triangle Park
Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company’s mission is to improve the lives of patients suffering from …See details»
Avolynt Company Profile - Office Locations, Competitors ... - Craft
Avolynt is a drug development company that offers medicines for patients suffering from dysfunctions related to human metabolism. It develops treatments for various diseases across …See details»
Avolynt, Inc. Company Profile | Durham, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Avolynt, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Avolynt - Contacts, Employees, Board Members, Advisors & Alumni
This company is improving the lives of patients suffering from dysfunctions in human metabolism and rare disease.See details»
Avolynt - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Avolynt . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... in funding over 1 round. This was a Grant round raised …See details»
Avolynt, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Avolynt, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:Remogliflozin etabonate, AVO-3235, AVO-1681. ... The statistics for drugs in the …See details»
Avolynt, Inc. Announces First Marketing Authorization and …
May 2, 2019 RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / May 2, 2019 / Avolynt, Inc., a company focused on the development of novel therapeutics for rare and metabolic diseases, …See details»
Management Team - avolynt
© 2020 by Avolynt, Inc. bottom of pageSee details»
Avolynt, Inc. Announces Positive Topline Data for Phase 2b BRID …
Dec 19, 2016 RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / December 19, 2016 / Avolynt Inc. ("Avolynt"), a privately held biotech company focused on the development of …See details»
Contact Us - avolynt
Get in touch with us to learn more ! Success! Message received. SendSee details»
Avolynt Announces Completion of Phase 2b BRID Study of SGLT2 …
Aug 9, 2016 Top-line Results to be Available in the Fourth Quarter of 2016 RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / August 9, 2016 / Avolynt, Inc. ("Avolynt"), a privately …See details»
Avolynt, Inc. Announces First Marketing Authorization and …
May 2, 2019 SUBMIT A PRESS RELEASE. Back to NewsroomSee details»
Development Pipeline - avolynt
© 2020 by Avolynt, Inc. bottom of pageSee details»
News - avolynt
Avolynt successfully randomized first subject into its phase 2b study in type 2 diabetics. The study is a U.S. based twelve-week multi-site, randomized, double blind, placebo controlled study of …See details»